Regulation of prolactin secretion during the estrus in rats: possible role of glucocorticoids

Abstract

Mifepristone (MIF) administration to cycling rats at proestrus induces hypersecretion of prolactin (PRL) at the following estrus. We aimed to assess whether this effect is due to the antiprogesterone or antiglucocorticoid action of MIF and to help underscore the nature of the circulating hormone(s) regulating PRL secretion at estrus. Female cycling rats in proestrus were treated with vehicle; the progesterone (Pg) and glucocorticoid receptor antagonists, MIF (5 mg/kg) or ORG-33628 (5 mg/kg); the glucocorticoid agonist dexamethasone (DEX; 27 mg/kg)GMIF; or the inhibitor of steroid synthesis aminoglutethimide (AG; 150 mg/kg)GMIF. The animals' blood was sampled the same day at 1800 h and at 1800 h of the following day to assess for circulating PRL and Pg levels. To distinguish antiglucocorticoid from antiprogesterone effects of MIF, we administered a highly specific neutralizing antibody against Pg. None of the antagonists modified serum PRL values at proestrus but increased PRL levels at estrus. DEX decreased the secretion of PRL at proestrus, yet the effect was entirely blocked by MIF. Furthermore, DEX decreased PRL at estrus in a MIF-reversible manner, suggesting that adrenal corticoids during proestrous may regulate PRL secretion at estrus. AG increased PRL secretion at estrus, whereas its association with MIF produced an even higher response. PRL concentration at estrus was not modified by the antiprogesterone antibody, suggesting that the effect of MIF is a consequence of its antiglucocorticoid effect and not due to its antiprogesterone properties. In conclusion, PRL secretion in the afternoon of the estrus is most likely regulated by glucocorticoids through an inhibitory action.

The role of prolactin/vasoinhibins in cardiovascular diseases

“…PRL activities are normally mediated by its specific highly affinitive receptor (PRLR), which is expressed in many tissues, especially the liver, breast, adrenal gland, and hypothalamus. 27 The PRLR is a member of the hematopoietic cytokine receptor superfamily and encoded by a gene located on chromosome 5p13‐14. PRLR consists of an extracellular domain that binds PRL, a single transmembrane domain, and a cytoplasmic domain.…”